FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics, and concerns a pharmaceutical composition for treating rheumatic and inflammatory diseases representing phospholipid nanoparticles sized 10-30 nm, including herbal phosphatidylcholine, maltose and indometacin in the following proportions, wt %: phosphatidylcholine 20-43, maltose 55-78, indometacin 2-8.
EFFECT: pharmaceutical composition exhibits higher antirheumatic and anti-inflammatory activity in oral and intravenous introduction.
1 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION BASED ON DOXORUBICINE AND PHOSPHOLIPID NANOPARTICLES FOR TREATMENT OF ONCOLOGIC DISEASES | 2009 |
|
RU2411935C1 |
| PHARMACEUTIC COMPOSITION INCLUDING ARBIDOL IN COMPOSITION OF PHOSPHOLIPID NANOPARTICLES | 2009 |
|
RU2411942C2 |
| BASED ON BOTANICAL PHOSPHOLIPIDS NANOSYSTEM FOR ACTUATION OF BIOLOGICALLY ACTIVE COMPOUNDS, AND METHOD OF ITS MANUFACTURE (VERSIONS) | 2009 |
|
RU2391966C1 |
| COMPOSITION FOR DRUG SUBSTANCE INTEGRATION INTO LIPID MATRIX, DRUG COMPOSITION WITH PHOSPHOLIPID FATTY ACID SYSTEM AND METHOD FOR PREPARING THEM | 2011 |
|
RU2463056C1 |
| PHOSPHOLIPID NANOPARTICLE INDOMETACIN APPLICABLE IN OPHTHALMOLOGY | 2011 |
|
RU2456979C1 |
| METHOD FOR PREPARING PHOSPHOLIPID NANOPARTICLE ENCLOSED CHLORINE E6 COMPOSITION FOR PHOTODYNAMIC THERAPY | 2013 |
|
RU2535054C1 |
| NANOFORM OF PHOSPHOLIPID PREPARATION FOR ORAL APPLICATION AND METHOD FOR MAKING THEREOF | 2008 |
|
RU2373924C1 |
| USE OF NANOPHOSPHOLIPID COMPOSITION OF RIFAMPICINE TOGETHER WITH PROTIONAMIDE OR ITS NANOPHOSPHOLIPID FORM IN TREATMENT OF TUBERCULOSIS | 2014 |
|
RU2595881C2 |
| ANTITUBERCULOUS COMPOSITION AND METHOD FOR PREPARING IT | 2011 |
|
RU2472512C1 |
| PHOSPHOLIPID COMPOSITION OF ECDISTEN EXHIBITING ADAPTOGENIC AND HEPATOPROTECTIVE ACTIVITY | 2013 |
|
RU2575561C2 |
